4D Molecular Therapeutics logo

4D Molecular Therapeutics FDMT

$ 7.86 -2.6%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Country

usaUSA

IPO year

2020

Industry

-

Stock Exchange

NASDAQ GLOBAL

CEO

-

Employees in the company

-

Shares

39.1 M

Market Cap[1]

$ 308 M

EBITDA (LTM)

$ -122 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.